Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study

被引：24

作者：

Layios N. ^{[1
,2
]}

Delierneux C. ^{[2
]}

Hego A. ^{[2
]}

Huart J. ^{[2
]}

Gosset C. ^{[3
]}

Lecut C. ^{[3
]}

Maes N. ^{[4
]}

Geurts P. ^{[5
]}

Joly A. ^{[5
]}

Lancellotti P. ^{[2
,6
]}

Albert A. ^{[4
]}

Damas P. ^{[1
]}

Gothot A. ^{[3
]}

Oury C. ^{[2
]}

机构：

[1] Department of General Intensive Care, University Hospital of Liège, Liège

[2] Laboratory of Thrombosis and Hemostasis, GIGA-Cardiovascular Sciences, University of Liège, Department of Cardiology, University Hospital of Liège, Liège

[3] Laboratory of Hematology, University Hospital of Liège, Liège

[4] Department of Biostatistics and Medico-Economic Information, University Hospital of Liège, Liège

[5] Systems and Modeling, Department of Electrical Engineering and Computer Science, University of Liège, Liège

[6] Gruppo Villa Maria Care and Research, Anthea Hospital, Bari

来源：

Intensive Care Medicine Experimental | / 5卷 / 1期

关键词：

Biomarker; Fibrinogen; Flow cytometry; Platelet markers; Prediction; Sepsis; SOFA;

D O I：

10.1186/s40635-017-0145-2

中图分类号：

学科分类号：

摘要：

Background: Platelets have been involved in both immune surveillance and host defense against severe infection. To date, whether platelet phenotype or other hemostasis components could be associated with predisposition to sepsis in critical illness remains unknown. The aim of this work was to identify platelet markers that could predict sepsis occurrence in critically ill injured patients. Methods: This single-center, prospective, observational, 7-month study was based on a cohort of 99 non-infected adult patients admitted to ICUs for elective cardiac surgery, trauma, acute brain injury, and post-operative prolonged ventilation and followed up during ICU stay. Clinical characteristics and severity score (SOFA) were recorded on admission. Platelet activation markers, including fibrinogen binding to platelets, platelet membrane P-selectin expression, plasma soluble CD40L, and platelet-leukocytes aggregates were assayed by flow cytometry at admission and 48 h later, and then at the time of sepsis diagnosis (Sepsis-3 criteria) and 7 days later for sepsis patients. Hospitalization data and outcomes were also recorded. Methods: Of the 99 patients, 19 developed sepsis after a median time of 5 days. These patients had a higher SOFA score at admission; levels of fibrinogen binding to platelets (platelet-Fg) and of D-dimers were also significantly increased compared to the other patients. Levels 48 h after ICU admission no longer differed between the two patient groups. Platelet-Fg % was an independent predictor of sepsis (P = 0.0031). By ROC curve analysis, cutoff point for Platelet-Fg (AUC = 0.75) was 50%. In patients with a SOFA cutoff of 8, the risk of sepsis reached 87% when Platelet-Fg levels were above 50%. Patients with sepsis had longer ICU and hospital stays and higher death rate. Conclusions: Platelet-bound fibrinogen levels assayed by flow cytometry within 24 h of ICU admission help identifying critically ill patients at risk of developing sepsis. © 2017, The Author(s).

引用

共 44 条

[1]

Angus D.C., van der Poll T., Severe sepsis and septic shock, N Engl J Med, 369, pp. 840-851, (2013)

[2]

Hotchkiss R.S., Monneret G., Payen D., Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach, Lancet Infect Dis, 13, pp. 260-268, (2013)

[3]

Morrell C.N., Aggrey A.A., Chapman L.M., Modjeski K.L., Emerging roles for platelets as immune and inflammatory cells, Blood, 123, pp. 2759-2767, (2014)

[4]

Clark S.R., Ma A.C., Tavener S.A., McDonald B., Goodarzi Z., Kelly M.M., Et al., Platelet tlr4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat Med, 13, pp. 463-469, (2007)

[5]

Aslam R., Speck E.R., Kim M., Crow A.R., Bang K.W., Nestel F.P., Et al., Platelet toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo, Blood, 107, pp. 637-641, (2006)

[6]

Semple J.W., Italiano J.E., Freedman J., Platelets and the immune continuum, Nat Rev Immunol, 11, pp. 264-274, (2011)

[7]

Weyrich A.S., Dixon D.A., Pabla R., Elstad M.R., McIntyre T.M., Prescott S.M., Et al., Signal-dependent translation of a regulatory protein, bcl-3, in activated human platelets, Proc Natl Acad Sci U S A, 95, pp. 5556-5561, (1998)

[8]

Thomas M.R., Storey R.F., The role of platelets in inflammation, Thromb Haemost, 114, pp. 449-458, (2015)

[9]

Yeaman M.R., Bayer A.S., Koo S.P., Foss W., Sullam P.M., Platelet microbicidal proteins and neutrophil defensin disrupt the staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action, J Clin Invest, 101, pp. 178-187, (1998)

[10]

Yeaman M.R., Tang Y.Q., Shen A.J., Bayer A.S., Selsted M.E., Purification and in vitro activities of rabbit platelet microbicidal proteins, Infect Immun, 65, pp. 1023-1031, (1997)

← 1 2 3 4 5 →